Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Pre-pandemic disease trajectories and genetic insights into long COVID susceptibility

  • Blay, Natalia
  • Farré, Xavier
  • García Aymerich, Judith
  • Castaño Vinyals, Gemma
  • Kogevinas, Manolis
  • Cid Ibeas, Rafael de
Background: Long COVID refers to the persistence of symptoms after SARS-CoV-2 infection. While individual comorbidities have been studied, the role of coexisting chronic conditions remains underexplored. This study investigates whether pre-pandemic disease trajectories-sequential patterns of chronic conditions-modify long COVID risk and symptom profiles and explores shared genetic susceptibility. Methods: We analysed 8322 adult participants (58.6% women) from the COVICAT cohort (aged 40-65 at recruitment), followed between 2020 and 2023. Disease trajectories were reconstructed from electronic health records (2010-2019), focusing on sequences of two chronic conditions found in ≥ 1% of the cohort. We evaluated shared genetic architecture and polygenic risk scores (PRS) for predictive capacity. Results: Thirty-eight disease trajectories were associated with increased long COVID risk. These trajectories primarily involved mental and neurological disorders (e.g. depression, anxiety, migraine), respiratory diseases (e.g. asthma, allergic rhinitis) and cardiometabolic or digestive conditions (e.g. hypertension, lipidaemia, obesity, gastroesophageal reflux). No significant genetic correlations with long COVID were detected, but polygenic risk scores for two nervous system and musculoskeletal conditions showed modest associations with increased risk. Conclusions: Disease trajectories were significantly associated with long COVID, with a sex effect, highlighting the importance of pre-pandemic disease trajectories. While no strong overall genetic correlations were found, modest polygenic associations suggest a role for shared susceptibility in nervous system and musculoskeletal disorders. From a public health perspective, identifying high-risk multimorbid individuals may inform targeted prevention and care strategies., La Caixa Foundation (SR20-01024), La Marató TV3 (167/C/2021), the Spanish Ministry of Health (PI18/01512), Spanish Ministry of Science and Innovation (TED2021-130626B-I00), Horizon Europe END-VOC (GA:101046314).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Environmental exposures and long COVID in a prospective population-based study in Catalonia (COVICAT study)

  • Saucy, Apolline
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Harding, Barbara N.
  • Karachaliou, Marianna
  • Ranzani, Otavio
  • Cid Ibeas, Rafael de
  • García Aymerich, Judith
  • Kogevinas, Manolis
This study makes use of data generated by the GCAT-Genomes for Life and Cohort study of the Genomes of Catalonia, Fundacio IGTP. IGTP is part of the CERCA Program/Generalitat de Catalunya. GCAT was funded by Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya (ADE 10/00026), with additional support by the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) (SGR 01537), Spanish National Grant PI18/01512, TED2021-130626B-I00, La MaratoTV3 167/C/2021, VEIS project (001-P-001647) [co-funded by European Regional Development Fund (ERDF), "A way to build Europe"], and the European Union under grant agreement number 101046314 (END-VOC). Additional data included in this study was obtained in part by the COVICAT Study Group (Cohort Covid de Catalunya) supported by ISGlobal and IGTP, EIT COVID-19 Rapid Response activity 20873A and SR20-01024 La Caixa Foundation. We acknowledge support from the Spanish Ministry of Science and Innovation and State Research Agency through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S) and from the Generalitat de Catalunya through the CERCA Program. A.S. received funding from the Swiss National Science Foundation (grant number P500PM_210781). B.H. received funding from the Instituto de Salud Carlos III (ISCIII) and the European Union NextGenerationEU/PRTR (grant IHMC22/00017).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia

  • Kogevinas, Manolis
  • Karachaliou, Marianna
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Delgado-Ortiz, Laura
  • Farré, Xavier
  • Blay, Natalia
  • Pearce, Neil E.
  • Bosch de Basea i Gómez, Magda, 1982-
  • Alonso Nogués, Eva
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Cid Ibeas, Rafael de
  • García Aymerich, Judith
Background: Long-COVID has mostly been investigated in clinical settings. We aimed to assess the risk, subtypes, persistence, and determinants of long-COVID in a prospective population-based study of adults with a history of SARS-CoV-2 infection in Catalonia. Methods: We examined 2764 infected individuals from a population-based cohort (COVICAT) established before the pandemic and followed up three times across the pandemic (2020, 2021, 2023). We assessed immunoglobulin (Ig)G levels against SARS-CoV-2, clinical, vaccination, sociodemographic, and lifestyle factors. Long-COVID risk and subtypes were defined based on participant-reported symptoms and electronic health records. We identified a total of 647 long-COVID cases and compared them with 2117 infected individuals without the condition. Results: Between 2021 and 2023, 23% of infected subjects developed long-COVID symptoms. In 56% of long-COVID cases in 2021, symptoms persisted for 2 years. Long-COVID presented clinically in three subtypes, mild neuromuscular, mild respiratory, and severe multi-organ. The latter was associated with persistent long-COVID. Risk was higher among females, participants under 50 years, of low socioeconomic status, severe COVID-19 infection, elevated pre-vaccination IgG levels, obesity, and prior chronic disease, particularly asthma/chronic obstructive pulmonary disease and mental health conditions. A lower risk was associated to pre-infection vaccination, infection after omicron became the dominant variant, higher physical activity levels, and sleeping 6-8 h. Vaccination during the 3 months post-infection was also protective against long-COVID. Conclusions: Long-COVID persisted for up to 2 years in half of the cases, and risk was influenced by multiple factors., We acknowledge support from the Horizon Europe END-VOC (grant agreement no. 101046314), Spanish Ministry of Science & Innovation (PID2019-110810RB-I00 grant); the Spanish State Research Agency and Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), the Instituto de Salud Carlos III (PI17/01555, PI18/01512), the La MaratoTV3 Foundation (167/C/2021), the Generalitat de Catalunya through the CERCA Program and the Fundació Privada Daniel Bravo Andreu; Xavier Farré is supported by VEIS project (001-P-001647, co-funded by European Regional Development Fund (ERDF). G.M. is supported by RYC 2020–029886-I/AEI/https://doi.org/10.13039/501100011033, co-funded by the European Social Fund (ESF). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination

  • Rubio, Rocío
  • Macià, Dídac
  • Barrios, Diana
  • Vidal, Marta
  • Jiménez, Alfons
  • Molinos-Albert, Luis M.
  • Díaz, Natalia
  • Canyelles, Mar
  • Lara Escandell, Maria
  • Planchais, Cyril
  • Santamaria, Pere
  • Carolis, Carlo
  • Izquierdo, Luis
  • Aguilar, Ruth
  • Moncunill, Gemma
  • Dobaño, Carlota
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) studies usually rely on cross-sectional data of large cohorts but limited repeated samples, overlooking significant inter-individual antibody kinetic differences. By combining Luminex, activation-induced marker (AIM) and IFN-γ/IL-2 Fluorospot assays, we characterized the IgM, IgA, and IgG antibody kinetics using 610 samples from 31 healthy adults over two years after COVID-19 vaccination, and the T-cell responses six months post-booster. Antibody trajectories varied among isotypes: IgG decayed slowly, IgA exhibited an initial sharp decline, which gradually slowed down and stabilized above the seropositivity threshold. Contrarily, IgM rapidly dropped to undetectable levels after primary vaccination. Importantly, three vaccine doses induced higher and more durable anti-spike IgG and IgA levels compared to two doses, whereas infection led to the highest antibody peak and slowest antibody decay rate compared to vaccination. Comparing with ancestral virus, antibody levels recognizing Omicron subvariants had a faster antibody decay. Finally, polyfunctional T cells were positively associated with subsequent IgA responses. These results revealed distinctive antibody patterns by isotype and highlight the benefits of booster doses in enhancing and sustaining antibody responses., This work was supported by the Fundació Privada Daniel Bravo Andreu and by the European Union under grant agreement no. 101046314 (END-VOC). RR had the support of the Health Department, Catalan Government (PERIS SLT017/20/000224). GM was supported by RYC 2020-029886-I/AEI/10.13039/501100011033, co-funded by European Social Fund (ESF). MLE received support from the grant 100046TC21_2022 INV-1 00046 funded by AGAUR/European Union NextGenerationEU/PRTR. PS was supported by PID2021-125493OB-I00 grant from the Spanish Ministry of Science and Innovation. We acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

  • Karachaliou, Marianna
  • Ranzani, Otavio
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Vidal, Marta
  • Jiménez, Alfons
  • Bañuls, Marc
  • Alonso Nogués, Eva
  • Aguilar, Ruth
  • García Aymerich, Judith
  • Cid Ibeas, Rafael de
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Kogevinas, Manolis
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

VEGFA sex-specific signature is associated to long COVID symptom persistence

  • Farré, Xavier
  • Blay, Natalia
  • Iraola Guzmán, Susana
  • Fernández-Jiménez, Francisco
  • Alzate-Piñol, Sayoa
  • Llucià-Carol, Laia
  • Espinosa, Ana
  • Castaño Vinyals, Gemma
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Karachaliou, Marianna
  • García Aymerich, Judith
  • Kogevinas, Manolis
  • Barceló, Carles
  • Cadenas, Israel
  • Cid Ibeas, Rafael de
Background: Long COVID involves persistent symptoms after COVID-19 recovery, affecting multiple organ systems for months or years. Risk factors include female sex, prior chronic conditions, severe SARS-CoV-2 infection, reinfections, and lack of vaccination. As a major public health concern, ongoing research continues to investigate its causes, mechanisms, and long-term effects. Methods: Proteomic expression analysis of 171 individuals, in two time points, with confirmed SARS-CoV-2 infection, including 133 long COVID patients from the deeply characterized COVICAT cohort, assessed 1395 protein biomarkers using Olink® technology. Statistical analyses with linear mixed models examined protein expression changes, long COVID status, and sex-specific differences. Functional analysis included gene set enrichment analysis and protein-protein interaction networks. Results: Findings revealed VEGFA overexpression in long COVID patients (effect size 0.322, SE = 0.098, p = 0.0013), along with sex-specific expression patterns and the influence of sex-hormonal status in females, with significant overexpression of circulating VEGFA levels specifically in postmenopausal women (Mann-Whitney U test p value = 8.55 × 10-3). Network analysis identified 109 nodes and 274 edges, with VEGFA ranking highest in centrality. Dysregulated chemokine signaling, complement activation, and viral reactivation were also confirmed, consistent with prior studies. Conclusions: Using high-throughput proteomic profiling in a population-based cohort, we observed that vascular dysfunction, particularly involving VEGFA, is a key feature of long COVID, especially in milder cases, with significant overexpression of VEGFA in postmenopausal women. Sex-specific proteomic patterns suggest distinct recovery mechanisms, highlighting the need to consider sex, vascular health, and disease severity in the pathogenesis and management of long COVID., La Caixa Foundation (SR20-01024), La Marató TV3 (167/C/2021), the Spanish Ministry of Science and Innovation (CEX2018-000806-S, CEX2023-0001290-S, TED2021-130626B-I00, RYC2020-029886-I), the Spanish Ministry of Health (PI18/01512, PI20/01267, MS19/00100), and Horizon Europe END-VOC (GA:101046314).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Risk, determinants, and persistence of long-COVID in a population-based cohort study in Catalonia

  • Kogevinas, Manolis
  • Karachaliou, Marianna
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Delgado-Ortiz, Laura
  • Farré, Xavier
  • Blay, Natalia
  • Pearce, Neil E.
  • Bosch de Basea i Gómez, Magda, 1982-
  • Alonso Nogués, Eva
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Cid Ibeas, Rafael de
  • García Aymerich, Judith
Background: Long-COVID has mostly been investigated in clinical settings. We aimed to assess the risk, subtypes, persistence, and determinants of long-COVID in a prospective population-based study of adults with a history of SARS-CoV-2 infection in Catalonia. Methods: We examined 2764 infected individuals from a population-based cohort (COVICAT) established before the pandemic and followed up three times across the pandemic (2020, 2021, 2023). We assessed immunoglobulin (Ig)G levels against SARS-CoV-2, clinical, vaccination, sociodemographic, and lifestyle factors. Long-COVID risk and subtypes were defined based on participant-reported symptoms and electronic health records. We identified a total of 647 long-COVID cases and compared them with 2117 infected individuals without the condition. Results: Between 2021 and 2023, 23% of infected subjects developed long-COVID symptoms. In 56% of long-COVID cases in 2021, symptoms persisted for 2 years. Long-COVID presented clinically in three subtypes, mild neuromuscular, mild respiratory, and severe multi-organ. The latter was associated with persistent long-COVID. Risk was higher among females, participants under 50 years, of low socioeconomic status, severe COVID-19 infection, elevated pre-vaccination IgG levels, obesity, and prior chronic disease, particularly asthma/chronic obstructive pulmonary disease and mental health conditions. A lower risk was associated to pre-infection vaccination, infection after omicron became the dominant variant, higher physical activity levels, and sleeping 6-8 h. Vaccination during the 3 months post-infection was also protective against long-COVID. Conclusions: Long-COVID persisted for up to 2 years in half of the cases, and risk was influenced by multiple factors., We acknowledge support from the Horizon Europe END-VOC (grant agreement no. 101046314), Spanish Ministry of Science & Innovation (PID2019-110810RB-I00 grant); the Spanish State Research Agency and Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S), the Instituto de Salud Carlos III (PI17/01555, PI18/01512), the La MaratoTV3 Foundation (167/C/2021), the Generalitat de Catalunya through the CERCA Program and the Fundació Privada Daniel Bravo Andreu; Xavier Farré is supported by VEIS project (001-P-001647, co-funded by European Regional Development Fund (ERDF). G.M. is supported by RYC 2020–029886-I/AEI/https://doi.org/10.13039/501100011033, co-funded by the European Social Fund (ESF). We acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/ https://doi.org/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

VEGFA sex-specific signature is associated to long COVID symptom persistence

  • Farré, Xavier
  • Blay, Natalia
  • Iraola Guzmán, Susana
  • Fernández-Jiménez, Francisco
  • Alzate-Piñol, Sayoa
  • Llucià-Carol, Laia
  • Espinosa, Ana
  • Castaño Vinyals, Gemma
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Karachaliou, Marianna
  • García Aymerich, Judith
  • Kogevinas, Manolis
  • Barceló, Carles
  • Cadenas, Israel
  • Cid Ibeas, Rafael de
Background: Long COVID involves persistent symptoms after COVID-19 recovery, affecting multiple organ systems for months or years. Risk factors include female sex, prior chronic conditions, severe SARS-CoV-2 infection, reinfections, and lack of vaccination. As a major public health concern, ongoing research continues to investigate its causes, mechanisms, and long-term effects. Methods: Proteomic expression analysis of 171 individuals, in two time points, with confirmed SARS-CoV-2 infection, including 133 long COVID patients from the deeply characterized COVICAT cohort, assessed 1395 protein biomarkers using Olink® technology. Statistical analyses with linear mixed models examined protein expression changes, long COVID status, and sex-specific differences. Functional analysis included gene set enrichment analysis and protein-protein interaction networks. Results: Findings revealed VEGFA overexpression in long COVID patients (effect size 0.322, SE = 0.098, p = 0.0013), along with sex-specific expression patterns and the influence of sex-hormonal status in females, with significant overexpression of circulating VEGFA levels specifically in postmenopausal women (Mann-Whitney U test p value = 8.55 × 10-3). Network analysis identified 109 nodes and 274 edges, with VEGFA ranking highest in centrality. Dysregulated chemokine signaling, complement activation, and viral reactivation were also confirmed, consistent with prior studies. Conclusions: Using high-throughput proteomic profiling in a population-based cohort, we observed that vascular dysfunction, particularly involving VEGFA, is a key feature of long COVID, especially in milder cases, with significant overexpression of VEGFA in postmenopausal women. Sex-specific proteomic patterns suggest distinct recovery mechanisms, highlighting the need to consider sex, vascular health, and disease severity in the pathogenesis and management of long COVID., La Caixa Foundation (SR20-01024), La Marató TV3 (167/C/2021), the Spanish Ministry of Science and Innovation (CEX2018-000806-S, CEX2023-0001290-S, TED2021-130626B-I00, RYC2020-029886-I), the Spanish Ministry of Health (PI18/01512, PI20/01267, MS19/00100), and Horizon Europe END-VOC (GA:101046314).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination

  • Rubio, Rocío
  • Macià, Dídac
  • Barrios, Diana
  • Vidal, Marta
  • Jiménez, Alfons
  • Molinos-Albert, Luis M.
  • Díaz, Natalia
  • Canyelles, Mar
  • Lara Escandell, Maria
  • Planchais, Cyril
  • Santamaria, Pere
  • Carolis, Carlo
  • Izquierdo, Luis
  • Aguilar, Ruth
  • Moncunill, Gemma
  • Dobaño, Carlota
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) studies usually rely on cross-sectional data of large cohorts but limited repeated samples, overlooking significant inter-individual antibody kinetic differences. By combining Luminex, activation-induced marker (AIM) and IFN-γ/IL-2 Fluorospot assays, we characterized the IgM, IgA, and IgG antibody kinetics using 610 samples from 31 healthy adults over two years after COVID-19 vaccination, and the T-cell responses six months post-booster. Antibody trajectories varied among isotypes: IgG decayed slowly, IgA exhibited an initial sharp decline, which gradually slowed down and stabilized above the seropositivity threshold. Contrarily, IgM rapidly dropped to undetectable levels after primary vaccination. Importantly, three vaccine doses induced higher and more durable anti-spike IgG and IgA levels compared to two doses, whereas infection led to the highest antibody peak and slowest antibody decay rate compared to vaccination. Comparing with ancestral virus, antibody levels recognizing Omicron subvariants had a faster antibody decay. Finally, polyfunctional T cells were positively associated with subsequent IgA responses. These results revealed distinctive antibody patterns by isotype and highlight the benefits of booster doses in enhancing and sustaining antibody responses., This work was supported by the Fundació Privada Daniel Bravo Andreu and by the European Union under grant agreement no. 101046314 (END-VOC). RR had the support of the Health Department, Catalan Government (PERIS SLT017/20/000224). GM was supported by RYC 2020-029886-I/AEI/10.13039/501100011033, co-funded by European Social Fund (ESF). MLE received support from the grant 100046TC21_2022 INV-1 00046 funded by AGAUR/European Union NextGenerationEU/PRTR. PS was supported by PID2021-125493OB-I00 grant from the Spanish Ministry of Science and Innovation. We acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Antibody responses to common viruses according to COVID-19 severity and postacute sequelae of COVID-19

  • Karachaliou, Marianna
  • Ranzani, Otavio
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Vidal, Marta
  • Jiménez, Alfons
  • Bañuls, Marc
  • Alonso Nogués, Eva
  • Aguilar, Ruth
  • García Aymerich, Judith
  • Cid Ibeas, Rafael de
  • Dobaño, Carlota
  • Moncunill, Gemma
  • Kogevinas, Manolis
Limited research suggests that certain viruses reactivate in severe-acute-respiratory-syndrome-coronavirus 2 infection, contributing to the development of postacute sequelae of COVID-19 (PASC). We examined 1083 infected individuals from a population-based cohort, and assessed differences in plasma immunoglobulin (Ig)G and immunoglobulin A levels against Epstein-Barr virus (EBV), cytomegalovirus, varicella zoster virus (VZV), BK polyomavirus, KI polyomavirus, WU polyomavirus (WUPyV), respiratory syncytial virus, and Adv-36 according to the severity of previous COVID-19 and PASC history. Individuals who had experienced severe COVID-19 had higher antibody responses to latent viruses. Ever PASC, active persistent PASC, and PASC with neuropsychiatric symptoms were associated with higher immnoglobulin G to EBV early antigen-diffuse, VZV, and WUPyV even among individuals without previous severe COVID-19.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Environmental exposures and long COVID in a prospective population-based study in Catalonia (COVICAT study)

  • Saucy, Apolline
  • Espinosa, Ana
  • Iraola Guzmán, Susana
  • Castaño Vinyals, Gemma
  • Harding, Barbara N.
  • Karachaliou, Marianna
  • Ranzani, Otavio
  • Cid Ibeas, Rafael de
  • García Aymerich, Judith
  • Kogevinas, Manolis
This study makes use of data generated by the GCAT-Genomes for Life and Cohort study of the Genomes of Catalonia, Fundacio IGTP. IGTP is part of the CERCA Program/Generalitat de Catalunya. GCAT was funded by Acción de Dinamización del ISCIII-MINECO and the Ministry of Health of the Generalitat of Catalunya (ADE 10/00026), with additional support by the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) (SGR 01537), Spanish National Grant PI18/01512, TED2021-130626B-I00, La MaratoTV3 167/C/2021, VEIS project (001-P-001647) [co-funded by European Regional Development Fund (ERDF), "A way to build Europe"], and the European Union under grant agreement number 101046314 (END-VOC). Additional data included in this study was obtained in part by the COVICAT Study Group (Cohort Covid de Catalunya) supported by ISGlobal and IGTP, EIT COVID-19 Rapid Response activity 20873A and SR20-01024 La Caixa Foundation. We acknowledge support from the Spanish Ministry of Science and Innovation and State Research Agency through the "Centro de Excelencia Severo Ochoa 2019-2023" Program (CEX2018-000806-S) and from the Generalitat de Catalunya through the CERCA Program. A.S. received funding from the Swiss National Science Foundation (grant number P500PM_210781). B.H. received funding from the Instituto de Salud Carlos III (ISCIII) and the European Union NextGenerationEU/PRTR (grant IHMC22/00017).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Pre-pandemic disease trajectories and genetic insights into long COVID susceptibility

  • Blay, Natalia
  • Farré, Xavier
  • García Aymerich, Judith
  • Castaño Vinyals, Gemma
  • Kogevinas, Manolis
  • Cid Ibeas, Rafael de
Background: Long COVID refers to the persistence of symptoms after SARS-CoV-2 infection. While individual comorbidities have been studied, the role of coexisting chronic conditions remains underexplored. This study investigates whether pre-pandemic disease trajectories-sequential patterns of chronic conditions-modify long COVID risk and symptom profiles and explores shared genetic susceptibility. Methods: We analysed 8322 adult participants (58.6% women) from the COVICAT cohort (aged 40-65 at recruitment), followed between 2020 and 2023. Disease trajectories were reconstructed from electronic health records (2010-2019), focusing on sequences of two chronic conditions found in ≥ 1% of the cohort. We evaluated shared genetic architecture and polygenic risk scores (PRS) for predictive capacity. Results: Thirty-eight disease trajectories were associated with increased long COVID risk. These trajectories primarily involved mental and neurological disorders (e.g. depression, anxiety, migraine), respiratory diseases (e.g. asthma, allergic rhinitis) and cardiometabolic or digestive conditions (e.g. hypertension, lipidaemia, obesity, gastroesophageal reflux). No significant genetic correlations with long COVID were detected, but polygenic risk scores for two nervous system and musculoskeletal conditions showed modest associations with increased risk. Conclusions: Disease trajectories were significantly associated with long COVID, with a sex effect, highlighting the importance of pre-pandemic disease trajectories. While no strong overall genetic correlations were found, modest polygenic associations suggest a role for shared susceptibility in nervous system and musculoskeletal disorders. From a public health perspective, identifying high-risk multimorbid individuals may inform targeted prevention and care strategies., La Caixa Foundation (SR20-01024), La Marató TV3 (167/C/2021), the Spanish Ministry of Health (PI18/01512), Spanish Ministry of Science and Innovation (TED2021-130626B-I00), Horizon Europe END-VOC (GA:101046314).